[FATE] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -13.34%
YoY- -58.56%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 14,981 14,225 7,558 2,429 1,026 1,026 1,026 56.30%
PBT -83,563 -43,308 -58,684 -26,609 -16,782 -10,684 -8,737 45.66%
Tax -2,828 -11,315 0 910 339 378 37 -
NP -80,735 -43,308 -58,684 -26,609 -16,782 -10,684 -8,737 44.83%
Tax Rate - - - - - - - -
Total Cost 95,716 57,533 66,242 29,038 17,808 11,710 9,763 46.27%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -538.92 -304.45 -776.45 -1,095.47 -1,635.67 -1,041.33 -851.56 -7.33%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.83 -0.45 -0.68 -0.40 -0.31 -0.26 -0.27 20.57%
EPS Diluted -0.83 -0.45 -0.68 -0.40 -0.31 -0.26 -0.27 20.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.